FDA Alerts

FDA
FDA
ATS Opposes FDA Approval of Over-the-Counter Epinephrine
11/14/2018
The American Thoracic Society says the FDA approved the asthma treatment with lack of consideration for patient safety and for a public policy process.
11/14/2018
opioids
opioids
FDA Approves Sublingual Opioid Despite Controversy
11/05/2018
The FDA has approved the sublingual opioid sufentanil (Dsuvia) fo
11/05/2018
genetics
genetics
FDA Approves First Genetic Test for Medication Metabolism
11/02/2018
The FDA has approved the first direct-to-consumer test to assess patients' ability to metabolize
11/02/2018
FDA
FDA
FDA Approves New Biosimilar
10/31/2018
The US Food and Drug Administration has approved adalimumab-adaz (Hyrimoz), a biosimilar to adalimumab (Humira), for the treatment of rheumatoid arthritis, juvenile...
10/31/2018
Rheumatologic disorders
Rheumatologic disorders
FDA Approves New Biosimilar
10/31/2018
10/31/2018
menopause
menopause
FDA Approves Menopausal Status Test
10/26/2018
The FDA has approved a test to help determine a patient’s menopau
10/26/2018
Influenza
Influenza
FDA: New Influenza Treatment
10/24/2018
The US Food and Drug Administration has approved baloxavir marboxil (Xofluza)
10/24/2018
FDA
FDA
Despite Warnings, Many Supplements Still Contain Undeclared Ingredients
10/15/2018
More than 50% of adults in the US have reported consuming dietary supplements, according to the study authors. However, warnings from the FDA of potential undeclared, unapproved pharmaceutical ingredients...
10/15/2018
cardiovascular disease
cardiovascular disease
FDA Approves Rivaroxaban for a New Indication
10/15/2018
New results from the COMPASS trial showed further cardiovascular benefits of rivaroxaban, when combined with aspirin. Find out the new indications here.
10/15/2018
HPV vaccination
HPV vaccination
FDA Expands HPV Vaccine Indication
10/09/2018
The FDA has expanded the age ranges of individuals who may receive the human papillomavirus 9-valent vaccine.
10/09/2018